Market News AIOpen the app

AbbVie Inc. shares details about its earnings and financial health.

ResultsRead the original at SEC EDGAR
Bad for ABBV

AbbVie expects research and milestone costs to cut third-quarter profit by $0.11 per share, weighing on its outlook. The quarter's figures are not final, and the filing names no matching business gain.

ABBV · AbbVie Inc.

AI read · Bad for ABBV

The AI's read

The added costs lower the profit AbbVie expects to report, which weighs on its outlook. The stated per-share hit is the clearest effect. The quarter's figures are not final, so the final amount could change. The filing gives no business gain tied to these costs.

Get alerts for ABBV

Follow AbbVie Inc. (ABBV) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ABBV
Free on the App Store and Google Play, or on the web.